<DOC>
	<DOCNO>NCT01114724</DOCNO>
	<brief_summary>The purpose study determine Valiant stent graft safe effective treating patient thoracic dissection . A thoracic dissection tear wall aorta , cause blood flow layer aorta force layer apart ( dissect ) . This condition medical emergency quickly lead death . Since stent graft effective way treat aortic condition aneurysms ( bulge aorta wall ) , believe device would effective treating dissection . Information collect performance device 5 year .</brief_summary>
	<brief_title>Study Evaluate Clinical Performance Valiant Thoracic Stent Graft With Captivia Delivery System ( Valiant Captivia ) Treatment Acute , Complicated Type B Aortic Dissections</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria Subject sign informed consent . Subject least 18 year old . Subject acute , complicate Type B aortic dissection evidence least one following : Malperfusion ( visceral , renal , spinal cord and/or lower limb ischemia ) Visceral ischemia measure either radiographic clinical evidence . Renal ischemia measure either radiographic clinical evidence . Spinal cord ischemia measure either radiographic clinical evidence . Lower limb ischemia measure either radiographic clinical evidence . Rupture Measured radiographic clinical evidence . Subject hemodynamically stable . Subject 's anatomy must meet follow anatomical criterion : Proximal land zone aortic diameter must 20 mm 44 mm ; Centerline distance distal margin leave CCA case bovine anatomy , innominate artery , start proximal tear must â‰¥ 20 mm ; Subject patent iliac femoral artery tolerate iliac conduit allow endovascular access dissection site delivery system appropriate size device . Thoracic aortic dissection confirm , minimum , diagnostic contrastenhanced computerized tomography angiogram ( CTA ) 3D reconstruction , and/or contrast enhance magnetic resonance angiogram ( MRA ) obtain prior implant procedure . Exclusion Criteria Planned placement COVERED portion stent graft leave carotid artery , celiac trunk . Subject systemic infection . Subject pregnant . Subject receive previous stent stent graft previous surgical repair DTA . Subject cerebral vascular accident ( CVA ) within 2 month . Subject history bleeding diathesis , coagulopathy , refuse blood transfusion . Subject history Marfan Syndrome connective tissue disorder . Subject currently participate investigational drug device clinical trial would interfere endpoint followups study . Subject know allergy intolerance device component . Subject know hypersensitivity contraindication anticoagulant contrast medium , amenable pretreatment . Subject comorbidity causing expect survival less 1 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Thoracic dissection</keyword>
	<keyword>Endovascular aortic repair</keyword>
</DOC>